Martelli A, Campart G B, Benvenuto F, Fresu A M, Brambilla G
Institute of Pharmacology, University of Genoa, Italy.
Mutat Res. 1993 Aug;292(1):63-7. doi: 10.1016/0165-1161(93)90008-n.
The frequencies of micronucleated erythrocytes were compared in bone marrow and spleen of mice killed 24 and 48 h after a single i.p. dose of one directly acting carcinogen, N-nitroso-N-ethylurea (NEU, 100 mg/kg), and two indirectly acting ones, N-nitrosodimethylamine (NDMA, 50 mg/kg) and 7,12-dimethylbenz[a]anthracene (7,12-DMBA, 50 mg/kg). The treated/control ratio of the incidence of micronucleated polychromatic erythrocytes (MnPCEs) was similar in the two tissues for NDMA at 24 h (sampling at 48 h was precluded by toxicity) and for 7,12-DMBA at 48 h, while it was higher in the bone marrow than in the spleen for NEU at both 24 and 48 h and for 7,12-DMBA at 24 h. Concerning micronucleated normochromatic erythrocytes (MnNCEs), their frequency in both tissues was always lower than that of MnPCEs; however, while in bone marrow a marked increase in their incidence was induced by NEU and 7,12-DMBA, any response was absent in spleen, thus suggesting that this organ does not sequester micronucleated erythrocytes. These results already indicate that the spleen is not a useful alternative to the bone marrow in the micronucleus assay. Moreover, counting of MnPCEs in the spleen is made more difficult and prone to error by the low frequency of PCEs, and by their greater toxicity-induced reduction. This last effect was found to be enhanced by the use of old mice.
单次腹腔注射一剂直接作用致癌物N-亚硝基-N-乙基脲(NEU,100毫克/千克)以及两剂间接作用致癌物N-亚硝基二甲胺(NDMA,50毫克/千克)和7,12-二甲基苯并[a]蒽(7,12-DMBA,50毫克/千克)后,在处死的小鼠骨髓和脾脏中比较微核红细胞的频率。对于NDMA在24小时时(因毒性无法在48小时取样)以及7,12-DMBA在48小时时,两个组织中多染性微核红细胞(MnPCEs)发生率的处理组/对照组比值相似,而对于NEU在24小时和48小时时以及7,12-DMBA在24小时时,骨髓中的该比值高于脾脏。关于正染性微核红细胞(MnNCEs),其在两个组织中的频率始终低于MnPCEs;然而,虽然在骨髓中NEU和7,12-DMBA可诱导其发生率显著增加,但在脾脏中未出现任何反应,这表明该器官不会截留微核红细胞。这些结果已表明,在微核试验中,脾脏并非骨髓的有用替代物。此外,脾脏中PCEs频率较低以及其因毒性导致的更大减少,使得脾脏中MnPCEs的计数更加困难且容易出错。发现使用老龄小鼠会增强这一最终效应。